Piper Jaffray Companies set a $42.00 target price on Phibro Animal Health Corporation (NASDAQ:PAHC) in a report issued on Friday morning. The brokerage currently has a buy rating on the stock.

Other equities research analysts also recently issued research reports about the stock. BidaskClub downgraded shares of Phibro Animal Health Corporation from a strong-buy rating to a buy rating in a research report on Wednesday, June 14th. Bank of America Corporation restated an underperform rating and issued a $33.00 price objective on shares of Phibro Animal Health Corporation in a research report on Wednesday, August 23rd. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a hold rating to a buy rating and set a $38.00 price objective for the company in a research report on Thursday, May 11th. Finally, Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an outperform rating to a neutral rating and raised their price objective for the company from $29.00 to $36.00 in a research report on Friday, June 2nd. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company’s stock. The company has a consensus rating of Hold and an average target price of $31.86.

Phibro Animal Health Corporation (NASDAQ:PAHC) opened at 37.25 on Friday. The company has a market capitalization of $1.48 billion, a P/E ratio of 23.14 and a beta of 1.35. The stock’s 50 day moving average price is $38.56 and its 200-day moving average price is $33.09. Phibro Animal Health Corporation has a one year low of $20.14 and a one year high of $40.25.

COPYRIGHT VIOLATION WARNING: “Piper Jaffray Companies Reiterates $42.00 Price Target for Phibro Animal Health Corporation (PAHC)” was published by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.watchlistnews.com/piper-jaffray-companies-reiterates-42-00-price-target-for-phibro-animal-health-corporation-pahc/1528797.html.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Shareholders of record on Wednesday, September 6th will be issued a $0.10 dividend. The ex-dividend date is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a yield of 1.07%. Phibro Animal Health Corporation’s dividend payout ratio (DPR) is presently 24.69%.

In other Phibro Animal Health Corporation news, major shareholder Bfi Co., Llc sold 48,000 shares of the stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $34.82, for a total value of $1,671,360.00. Following the completion of the transaction, the insider now directly owns 96,000 shares of the company’s stock, valued at $3,342,720. The sale was disclosed in a filing with the SEC, which is available at this link. Also, VP Daniel M. Bendheim sold 4,976 shares of the stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $40.01, for a total transaction of $199,089.76. Following the completion of the transaction, the vice president now directly owns 4,176 shares of the company’s stock, valued at $167,081.76. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 268,657 shares of company stock valued at $9,802,503. 48.09% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Janus Henderson Group PLC bought a new position in shares of Phibro Animal Health Corporation during the second quarter worth about $6,353,000. AJO LP bought a new position in shares of Phibro Animal Health Corporation during the second quarter worth about $5,815,000. FMR LLC boosted its position in shares of Phibro Animal Health Corporation by 31.9% in the second quarter. FMR LLC now owns 584,463 shares of the company’s stock worth $21,654,000 after buying an additional 141,274 shares during the period. Vanguard Group Inc. boosted its position in shares of Phibro Animal Health Corporation by 8.2% in the first quarter. Vanguard Group Inc. now owns 1,729,406 shares of the company’s stock worth $48,597,000 after buying an additional 130,935 shares during the period. Finally, Ameriprise Financial Inc. boosted its position in shares of Phibro Animal Health Corporation by 50.6% in the second quarter. Ameriprise Financial Inc. now owns 339,996 shares of the company’s stock worth $12,599,000 after buying an additional 114,230 shares during the period. 48.35% of the stock is owned by institutional investors.

About Phibro Animal Health Corporation

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Analyst Recommendations for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.